ArticleThe Pan African medical journal2025
Prevalence of presumptive clinical signs of breast cancer among women attending an early detection campaign in Lomé in 2023.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: breast cancer is the most common cancer in women in Togo. Screening and early diagnosis campaigns are organised to limit the late use of health services. The aim of this study was to determine the prevalence of presumptive clinical signs of breast cancer and to identify associated factors in Lomé. Methods: a multicentre cross-sectional study was conducted in October 2023 in the commune of Lomé, Togo. Sampling was non-probability and voluntary. Data were collected using a digital questionnaire during the clinical examination of patients. Data were processed and analysed using R 4.3.2 software. Univariate and multivariate regression analysis were used to identify associated factors. Results: a total of 151 participants took part in the study. The largest group was aged between 18 and 24. The median age of the participants was 29 years, with an interquartile range IIQ: 23 years - 41 years. The prevalence of clinical signs of breast cancer was 35.5%. A nodule in the breast was the main symptom (24.8%), followed by breast discharge (8.3%). The number of children (ORa = 1.84; p = 0.030) was significantly associated with the presence of clinical signs of breast cancer. Conclusion: the prevalence of presumptive clinical signs of breast cancer among women during a mass early detection campaign is high. It highlights the crucial importance of early detection through mass population campaigns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.